A B S T R A C T The beige mouse, C57BL/6 (bg/bg), is ain aniimal model for the Chediak-Higashi syndrome in main, a disease characterized morphologically by giant lysosomes in most cell types. Half-lives for the turnover of [14C]bicarbonate-labeled total soluble liver protein were determined in normal and beige mice. No significant differences were observed between the niormal and mutant strain for both rapidly and slowly turniing-over classes of proteins. Glucagon treatment durinig the time-course of protein degradation had simiiilar effects on both normal and mutant strains anid led to the conclusion that the rate of turnover of endogenous intracellular protein in the beige mouse liver does not differ from normal.
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The rates of uptake and degradation of an exogenous protein were determined in normal and beige mice by intravenously injecting 1251-bovine serum albumin and followinig, in peripheral blood, the loss with time of phosphotungstic acid-insoluble bovine serum albumin and the parallel appearance of phosphotungstic acid-soluble (degraded) material. No significant differences were observed between beige and normal mice in the uptake by liver lysosomes of 1251_ bovine serum albumin (t,/2 = 3.9 and 2.8 h, respectively). However, it was found that lysosomes from livers of beige mice released phosphotungstic acidsoluble radioactivity at a rate significantly slower than normal (t,2 = 6.8 and 3.1 h, respectively). This defect in beige mice could be corrected by chronic admiiinistration of carbamyl choline (t,,2 = 3.5 h), a cholinergic agonist which raises intracellular cyclic GMP levels. However, no significant differences be- 
INTRODUCTION
The beige mouse is an animal model for the human Chediak-Higashi (CH)' syndrome, a rare autosomal recessively inherited disease. The disease is characterized by large granules (lysosomes) in most cell types, partial albinism, increased susceptibility to pyogenic infections, and several functional abnormalities of leukocytes including defective lysosomal degranulation and impaired chemotaxis. Thus far, the disease has been described in man, mink, cattle, and mice (2) (3) (4) (5) (6) (7) .
Although the exact biochemical defect is not known, recent reports have indicated that lysosomes may accumulate in the beige mouse because of defective exocytosis resulting either from decreased intracellular motility of lysosomes or from their improper fusion with the plasma membrane. Brandt et al. (8) have reported that beige mice treated with androgen had significaritly higher levels of three hydrolytic lysosomal enzymes in kidney than the normal parent strain (C57BL/6). Excretion into the urine is a major mechanism of removal of lysosomal enzymes from normal mouse kidney. Brandt et al. proposed that this process is impaired in beige mice because of an abnormal fusion of lysosomes with the plasma membrane of the kidney proximal tubule cells.
Oliver and co-workers (9, 10) studied the mobility of concanavalin A receptor complexes on polymorpho-nuclear leukocyte (PMN) membranes as a test of microtubule integrity. They reported that normal PMNs showed uniform distribution of membranebound concanavalin A. By contrast, concanavalin A was aggregated into surface "caps" on both colchicine-treated normal PMNs and untreated PMNs from either beige mice or human CH patients.
The spontaneous capping response of PMNs of the beige mouse in vitro was inhibited by cyclic (c)GMP and by cholinergic agonists such as carbamyl choline that raise intracellular cGMP levels. Oliver et al. also reported that these drugs and cGMP itself prevented the formation of giant lysosomes in cultured embryonic fibroblasts froin beige mice (11) .
These responses can also be reproduced in vivo in the beige mouse (9) . Animals treated with low levels of cholinergic agonists show normal granule morphology and a normal degree of concanavalin Ainduced cap formation in peripheral blood PMN. These findings led to a hypothesis that defective cGMP generation underlies all characteristic changes seen in the disease.
Because ascorbic acid potentiates chemotaxis of normal leukocytes, Boxer et al. (12) examined the effects of ascorbate on PMNs from Chediak-Higashi patients. They reported that cAMP levels in PMNs of such patients were an order of magnitude higher than normal. Ascorbic acid treatment, both in vitro and in vivo, reduced cAMP levels and corrected functional defects in PMNs from patients with CH syndrome. They hypothesized that cGMP, which also appeared to correct CH leukocyte function in vitro, may act by antagonizing the effect of excessive cAMP. Thus cAMP may inhibit both microtubular assembly (13) and chemotaxis (14) while cGMP potentiates these processes in normal leukocytes.
The lysosome is widely believed to be involved in the degradation of proteins of intracellular (15) (16) (17) (18) , serum (19, 20) , and foreign (15, 21) origin. Because the beige mouse exhibits abnormally enlarged lysosomes in most cell types, we have compared the turnover of endogenous and exogenous proteins in normal and beige mice. In addition, we have examined both the levels of cAMP and the binding of [3H]cGMP in normal and beige mouse tissue extracts. These assays were performed because the uptake of materials by lysosomes may involve cAMP and microtubule integrity (22, 23) . Defective microtubule formation in the beige mouse may in turn be the result of abnormal cyclic nucleotide metabolism.
METHODS
Animals. Male inbred C57BL/6 mice were purchased from Sprague-Dawley (Madison, Wis.); male C57BL/6 (bg/bg) mice were obtained from the Jackson Laboratory, Bar Harbor, Maine, and were bred at the McArdle Laboratory. Both strains were utilized at 3-4 mo of age. The aniimals were maintained on a 12-h light-12-h dark schedule, and were fed ad libitum on Purina chow (Ralston Purina Co., St. Louis, Mo.).
Turnover of endogenous liver proteins. Where indicated, glucagon (200 ,ug/day per mouse) was administered subcutaneously as a 1:1 emulsion with trioctanioini (24) . All mice were injected with 100 ,uCi NaH'4CO3 (60( mCi/mmllol) and were killed by cervical dislocation at times indicated. Livers were homogenized in 4 ml of 0.25 M sucrose-0.05 NI Tris, pH 7.8-0.025 M KC1-0.005 M MgCl2 and were centrifuged for 10 min at 10,000 rpm (Sorvall SS-34 rotor, DuPont Co., Instrument Products Div., Wilmington, Del.).
The resulting supernates were then recentrifuged for 1 h at 45,000 rpm (Beckman 50 Ti rotor, Beckman Instrumenits, Inc., Spinco Div., Palo Alto, Calif.). These final supernatanit (S3) fractions were stored frozen at -200C.
50-,lI aliquots of S3 were pipetted in duplicate on glass fiber discs (Whatman GF/C, 2.4 cm, Fisher Scientific Co., Pittsburgh, Pa.), the proteins were precipitated in 10% trichloroacetic acid, and the discs were washed as describedl previously (24) . Radioactivity was determined with toluene-2,5-diphenyloxazole on a Nuclear Chicago scinitillation counter at about 25% efficiency.
A second set of duplicate discs containing 50-,ul aliquots of S3 was washed by the same procedure and was used for protein determinations. These washed discs were incubated overnight in scintillation vials containing 2 ml of 1 N NaOH to dissolve the protein. 100-,ul aliquots were removed for protein determination by the method of Lowry et al. (25) .
Uptake and degradation of 1251-BSA. All mice received 0.01% Nal (wt/vol) in their drinking water for at least 1 wk before use in these experiments to minimize uptake of iodide by the thyroid gland. Where indicated, some groups also received 0.02% (wt/vol) carbamyl choline for at least 1 wk in their drinking water (9), which was changed daily. Animals were lightly anesthetized with Nembutal and were injected via the tail vein with 50 ,ul of a solutioni containing 20 ,uCi 1251-bovine serum albumin (BSA) with-nonradioactive carrier BSA to a total of 100 ,ug protein. A Hamilton microliter syringe was used when precise measurements of uptake were desired, as described by Davidson et al. (26) . At suitable intervals, duplicate 20O-/il blood samples were taken in heparinized disposable micropipets by slicing 1 mm of tissue from the end of the tail. Bloodl samples were immediately added to 1-ml aliquots of phosphotungstic acid (PTA) reagent (0.375% PTA in 0.5% HCI), vortexed and allowed to stand at least 15 min on ice. The tubes were then centrifuged for 30 min at 2,800 rpm in a Sorvall GLC-1 centrifuge (DuPont Co., Instrument Products Div.) located in a cold room. The precipitates were washed twice in 1-ml aliquots of cold PTA reagent; tubes containing these precipitates were placed in plastic tissue culture tubes (no. 3033, Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). The three supernates (original plus two washes) were combined in other culture tubes, and the radioactivity was determined with a gamma counter (Amersham/Searle Corp., Arlington Heights, Ill.) at 75% efficiency for 1251. In experiments designed to measure the organi distributioni of injected '251-BSA, animals were perfused through the heart with cold physiological saline, as described by Davidson et al. (26) , until livers and kidneys had blanched free of blood.
Cyclic GMP binding assay. The cGMP binding assay was Protein Degradation in Normal and Beige (Chediak-Higashi) Mice performed with a variation of the method of Lincoln et al. (27) . Male mice were killed by cervical dislocation, and the tissues were quickly excised and homogenized in 2 vol of 25 mM Na phosphate, pH 7.4, containing 2 mM EDTA and 10 mM dithiothreitol. The homogenates were centrifuged at 10,000 rpm for 15 min (Sorvall SS-34 rotor), and the resulting postmitochondrial supernate was centrifuged at 45,000 rpm for 90 min (Beckman 50 Ti rotor). Aliquots of the resulting high-speed supernate (S3) were used for both cGMP binding and protein determination by the biuret method (28) .
The binding assay was performed in a total volume of 0.12 ml and contained, in order of addition: 0.03 ml of 25 mM Na phosphate, pH 7.4; 2 mM EDTA; 0.02 ml of 2.5 mM 3-isobutyl 1-methylxanthine; 0.02 ml of [3H]cGMP (0.1-5 pmol); and 0.05 ml S3. To estimate nonspecific binding of radioactivity, blank discs were assayed with aliquots of BSA (30 mg/ml) added in place of S3. Blank values were routinely subtracted from the radioactivity values of the assay discs. 3-isobutyl 1-methylxanthine, an inhibitor of cGMP phosphodiesterase (29) , was first dissolved in 20% ethanol with phosphate-EDTA buffer (same as above) and then added to volume. The assay mixture was incubated in 3-ml glass centrifuge tubes for 60 min on ice. At the end of this time period, 2 ml of cold phosphate-EDTA buffer was added to each tube, and the contents were quickly filtered through Millipore filters (2.5-cm diameter, type HA, 0.45-,um pore size) with a Millipore sampling manifold (Millipore Corp., Bedford, Mass., no. 2702550). The tubes and filters were washed four times; twice with 2-ml aliquots of phosphate-EDTA buffer and then twice with 2-ml aliquots of 10 mM MgCl2. The filters were placed in scintillation vials and then air dried at 90°C. After adding 5 ml of toluene-2,5-diphenyloxazole, bound radioactivity was determined in a Nuclear-Chicago scintillation counter at about 25% efficiency.
Glucagon was purchased from Eli Lilly and Co., Indianapolis, Ind.; trioctanoin from Eastman Chemical Products, Inc., Kingsport, Tenn.; phosphotungstic acid from Mallinckrodt Chemical Works, St. Louis, Mo.; and 3-isobutyl-1-methylxanthine from Aldrich Chemical Co., Milwaukee, Wis. Carbamyl choline and Trizma base were products of the Sigma Chemical Co., St. Louis, Mo. 125I-BSA (6-60 Ci/mmol) was obtained from New England Nuclear, Boston, Mass. Both NaH14CO3 (60 mCi/mmol) and [8-3H] cGMP (21 Ci/mmol) were purchased from Amersham/Searle Corp.
RESULTS
To determine whether or not the abnormally large lysosomes found in all tissues of the beige mouse are associated with any aberrations in the overall rate of intracellular protein degradation, half-lives for [14C]bicarbonate-labeled soluble liver proteins were determined. Mice were each injected with 100 ,Ci of NaH14CO3 (30) and then killed at specified intervals. Radioactivity per milligram protein was determined in aliquots of liver cytosol as described under Methods.
The results of a 137-h experiment designed to measure the mean half-life of a slowly turning-over class of liver proteins are shown in Fig. 1 . A similar experiment that measures the mean half-life of more labile liver proteins by following an 8-h time-course is shown in Fig. 2 . Table I summarizes the results of a series of such protein degradation studies. FIGURE 1 Turnover of total soluble liver protein in normal C57BL/6 mice. Mice were injected with 100 l Ci NaH'4CO3 and killed in groups of three at the times indicated. Pooled liver homogenates were centrifuged as described under Methods to obtain postmicrosomal supernatant fractions. Aliquots of these supernatants were pipetted onto glass fiber discs, the proteins were precipitated with cold 10% trichloroacetic acid, and nonprotein-bound radioactivity was removed by sequential washings as described previously (24) . Radioactivity per milligram protein on each disc was determined as described under Methods. No significant differences were observed between normal and beige mice in the turnover of either class of soluble liver proteins. The effect of treatment of mice with glucagon was tested inasmuch as it has been reported that this hormone induces autophagic vacuole formation and alters several physical properties of lysosomes (31) (32) (33) . A single intraperitoneal injection of 100 ,g of glucagon per day slowed the degradation of the more rapidly turningover class of proteins somewhat, but had only a slight effect on the half-life of the more stable class (Table I) . Again, no significant differences between normal and beige mice were observed.
Because it was apparent that the degradation of endogenous intracellular liver protein was not impaired in beige mice, the ability of these animnals to degrade exogenous protein was examined. A typical timle-course for the disappearance of native 1251-BSA and the parallel appearance of degraded fragments in the peripheral blood is shown in Fig. 3 . These processes were essentially linear for at least 4 h when plotted semilogarithmically. The removal of '25I-BSA from the blood is accomplished in vivo by pinocytosis and results in the formation of pinocytotic vacuoles in liver and kidney cells (34) (35) (36) . These vacuoles fuse with primary lysosomes, resulting in the formation of secondary lysosomes. These bodies are the site of degradation of exogenous proteins (15, 21, 26, 37 ). The secondary lysosomes may then migrate to and fuse with the plasmna memeibrane where the degraded fragments are discharged into the extracellular compartment by exocvtosis. Tables II and III summarize the apparent half-lives for the processing of (1251)-BSA by these mechanisms, as determined from the slopes of the logarithmic plots.
It was observed (Table II) that untreated beige mice had a smiall but significant (P < 0.005) impairment in the rate of' uptake of 1251-BSA compared with normal. When mice were treated with 100 ,ug of glucagon 1 h before 125I-BSA injection, there was a small inlcrease in the half-life of circulating native BSA in both strains. This increase was significant (P < 0.0025) for niormal mice but not significant for the mutant group. Wheni animals were treated with low levels of the cholinergic agonist, carbamyl choline, in their drinkiing water, the rate of BSA uptake for each strain was not significantly different from that of untreated controls.
The half-life for the appearance of circulating PTAsoluble fragments of BSA is shown in Table III . The half-life for this process in beige mice was more than twice that observed in normal mice. Glucagon treatment caused almost a fourfold increase in this half-life for normal mice with no change in this parameter in beige mice. Carbamyl choline administration reversed this defect in the mutant mice in that the release of PTA-soluble radioactivity under these conditions occurred at a rate not significantly different from normal.
To determine which organ took up most of the injected 1251-BSA, grouips of normal mice were killed at (26) .
intervals after injection, and their livers and kidneys were blanched in situ with physiological saline as described in Methods. This perfusion removed most of the radioactive blood from these organs and permitted an estimate of bound intracellular 125I-BSA. As shown in Fig. 4 , 34% of the injected radioactivity remained in the extracellular (blood) compartment after 5 min, with 18% and 6% in the liver and kidney, respectively. After 30 or 60 min, the liver still held over three times the radioactivity found in the kidney. Thus the liver appears to be the primary site of 125I-BSA degradation. When this experiment was repeated with beige mice, essentially identical results were obtained (data not shown). Oliver and Zurier (9) have reported that cGMP and two analogs of acetylcholine (carbamyl choline and carbamyl-,8-methylcholine) which elevate intracellular cGMP levels (38) canl reverse the abnormal Glucagon (n = 5) 11 .8±1.1 6.7±0.5
Carbamyl choline (n = 4) 3.4+±0.4
3.5±0.5
The protocol is described under Methods. Half-lives were calculated as described under (21, 32) . Under the conditions in our studies (Table IB) , glucagon treatment appeared to have no effect on the turnover of the more stable class of' soluble liver proteins and to prolong somewhat the mean half-life of the more rapidly turning over group. The latter effect may be due to a hormonally-induced shift in synthesis to a slightly different class of proteins with a different mean half-life, or it may be an artefact due to the enhanced fixation of [14C ]bicarbonate in the presence of greater activity of pyruvate carboxylase.
In either case, the coniclusion remainis that the turnover of endogenous soluble liver proteins was unaffected by the beige mutation. Padgett et al. (43) reported that 48 hr after normal and beige mice were injected intravenously with horseradish peroxidase, the lysosomes of normal mice had digested almost all of the horseradish peroxidase, whereas large amounts were still present in CH mice at this time. Using ultrastructural cytochemistry, these authors did not find anly gross differences between normal and beige animals in the pinocytotic uptake of this foreign protein, but rather in the lysosomal processing. Consistent with these results, the present study concludes that the uptake of'another foreign protein, 1251-BSA, is slightly but significantly reduced in beige mice (Table II) , but that the release of PTA-soluble fragments is markedly impaired (Table III) .
The half-life for the degradation of '25I-BSA in normal mice reported here is about 3 h. Gabathuler and Ryser (44) reported a half-life of 90 min for the degradation of 131I-albumin by Sarcoma S180 cells in culture. These values are considerably greater than the half-lives reported by Davidson (45) for the degradation of 125I-ribonuclease by mouse kidney lysosomes: 14 min in vivo and 11 min in vitro. These differences may possibly be related to the reported observation that 55% of injected 1251-ribonuclease was absorbed by mouse kidney after 7 min (26), whereas in this present study (Fig. 4) peak absorption of 125I-BSA did not occur until about 30 min after injection. At this time, 28% of the label was bound in liver and only 8% in kidney. The preferential uptake of BSA by liver and ribonuclease by kidney may be related to the large molecular weight difference between the two proteins (67,000 for BSA and 14,000 for ribonuclease).
The nature of the presumed defect in cyclic nucleotide metabolism in CH cells has not yet been elucidated. In addition, the precise role of cGMP in microtubule assembly is not understood. Inasmuch as microtubule assembly in vitro is promoted by reduced glutathione (46) and inhibited by calcium ions (47) , cGMP may represent an intermediate in the reaction. Although we have found no significant differences in total cGMP binding proteins of normal vs. beige mice (Table V) , it is still possible that the cGMPdependent protein kinase of beige mice has an altered affinity for cGMP. If this kinase were involved in microtubule assembly, this would explain the reversal of abnormalities in lysosomal morphology and function observed in vivo and in vitro when CH cells are exposed to agents which raise intracellular cGMP levels. The cGMP-dependent protein kinases of normal and beige mice are currently being compared in this laboratory.
In the studies described herein (Table VI) , no elevation of cAMP levels in beige mouse liver or kidney cells was seen. The report by Boxer et al. (12) of a 10-fold elevation of cAMP in human CH PMNs compared with normal may be a phenomenon characteristic of the human CH leukocytes only. The hypothesis by Boxer et al. that excess cAMP inhibits microtubule assembly in CH leukocytes is contrary to the results of DiPasquale et al. (48) , who report that cAMP actually increases the ratio of polymerized to unpolymerized tubulin in cultivated Greene melanoma cells. A complete description of the biochemical defect underlying the CH syndrome may not be forthcoming until the mechanism of microtubule assembly is more fully understood.
